journal Journal For International Medical Graduates Journal For International Medical Graduates California Institute of Behavioral Neurosciences and Psychology US https://www.cibnp.com 2832-9864 218 Articles Atypical First-Episode Psychosis With Prolonged Catatonia and Neuroleptic Malignant Syndrome: Diagnostic Challenges and Improvement With Clozapine: A Case Report and Literature Review Aditi Sarker, MD Sarker Aditi aditixavier14@gmail.com Adil Elahi, MD Elahi Adil adil.elahi@jimgs.com Gursimrat Bhatti, MD Bhatti Gursimrat gursimrat.bhatti@jimgs.com Abraham Williams, DO Williams Abraham abraham.williams@jimgs.com Muhammad Yusuf, MD Yusuf Muhammad muhammad.yusuf@jimgs.com David Murdock, MD Murdock David david.murdock@jimgs.com Nhu Mai Vu, MD Mai Vu Nhu nhu.mai.vu@jimgs.com Michael Gillespie, MD Gillespie Michael michael.gillespie@jimgs.com Raheel Imtiaz Memon, MD Memon Raheel Imtiaz raheel.ımtiaz.memon@jimgs.com PGY2 Resident, Psychiatry Residency Program, Baptist Hospitals of Southeast Texas, Beaumont, TX PGY1 Resident, Psychiatry Residency Program, Baptist Hospitals of Southeast Texas, Beaumont, TX Core Faculty, Psychiatry Residency Program, Baptist Hospitals of Southeast Texas, Beaumont, TX Child and Adolescent Psychiatry Specialist, Baptist Hospitals of Southeast Texas, Beaumont, TX Program Director, Psychiatry Residency Program, Baptist Hospitals of Southeast Texas, Beaumont, TX Child, Adolescent & Adult Psychiatrist, Medical Director, Associate Program Director, Psychiatry Residency Program, Baptist Hospitals of Southeast Texas, Beaumont, TX 23 01 2026 Received: 2312026 Copyright (c) 2026 Journal For International Medical Graduates 2026 Journal For International Medical Graduates Schizophrenia psychotic disorder DSM-5 catatonia NMS neuroinflammation antipsychotics clozapine Velligan, I. D., Rao, S. The epidemiology and global burden of schizophrenia. J Clin Psychiatry. 2023; 84 (1):MS21078COM5. https://doi.org/10.4088/JCP.MS21078COM5. Marder, SR., Cannon TD. Schizophrenia. N Engl J Med. 2019; 381 (18):1753-1761. PMID: 31665579. doi: 10.1056/NEJMra1808803 Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015; 72 (12):1172-1181. doi:10.1001/jamapsychiatry.2015.1737 Jablensky, A. The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues in Clinical Neuroscience. 2010; 12 (3): 271–287. https://doi.org/10.31887/DCNS.2010.12.3/ajable nsky Huq, R., Mithani, F., Cullum, S., & Chacko, R. An atypical progression of schizophrenia in an elderly woman. Proceedings (Baylor University. Medical Center). 2020; 34 (2): 321. https://doi.org/10.1080/08998280.2020.1834906 Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); June 2016. https://www.ncbi.nlm.nih.gov/books/NBK519704/ table/ch3.t22/ Patel, K. R., Cherian, J., Gohil, K., & Atkinson, D. Schizophrenia: Overview and treatment options. Pharmacy and Therapeutics. 2014; 39 (9): 638. https://pmc.ncbi.nlm.nih.gov/articles/PMC4159061/ Pandey, A., & Kalita, K. N. Treatment-resistant schizophrenia: How far have we traveled? Frontiers in Psychiatry. 2022; 13: 994425. https://doi.org/10.3389/fpsyt.2022.994425 Siskind D, Orr S, Sinha S, et al. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis. The British Journal of Psychiatry. 2022; 220(3):115-120. doi:10.1192/bjp.2021.61 Remington, G., Agid, O., Foussias, G., Hahn, M., Rao, N., Sinyor, M. Clozapine’s Role in the Treatment of First-Episode Schizophrenia. Am J Psychiatry. 2013; 170:146–151. https://doi.org/10.1176/appi.ajp.2012.12060778 Phiri, P., Delanerolle, G., Hope, O., et al. Catatonia: A deep dive into its unfathomable depths. World Journal of Psychiatry. 2024; 14 (2): 210. https://doi.org/10.5498/wjp.v14.i2.210 Ungvari GS, Leung SK, Ng FS, Cheung H-K, Leung T. Schizophrenia with prominent catatonic features (’catatonic schizophrenia’): I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29:27–38. doi:10.1016/j.pnpbp.2004.08.007 Stuivenga, M., & Morrens, M. Prevalence of the catatonic syndrome in an acute inpatient sample. Frontiers in Psychiatry. 2014; 5: 121778. https://doi.org/10.3389/fpsyt.2014.00174 Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996; 93: 129–136. Doi: 10.1111/j.1600-0447.1996.tb09814.x. Tandon, R., Heckers, S., Bustillo, J., et al. Catatonia in DSM-5. Schizophrenia Research. 2013; 150 (1): 26-30. https://doi.org/10.1016/j.schres.2013.04.034 Simon LV, Hashmi MF, Callahan AL. Neuroleptic Malignant Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 24, 2023. https://www.ncbi.nlm.nih.gov/books/NBK482282/ Rodriguez, S., Dufendach, K. A., & Weinreib, R. M. Neuroleptic malignant syndrome or catatonia? A Case Report. The Journal of Critical Care Medicine. 2020; 6 (3): 190. https://doi.org/10.2478/jccm-2020-0025 Hirjak, D., Sartorius, A., Kubera, K. M., & Wolf, R. C. Antipsychotic-induced catatonia and neuroleptic malignant syndrome: The dark side of the moon. Molecular Psychiatry. 2021; 26 (11): 6112-6114. https://doi.org/10.1038/s41380-021-01158-2 Tsuang MT, Dempsey M, Rauscher F. A study of "atypical schizophrenia". Comparison with schizophrenia and affective disorder by sex, age of admission, precipitant, outcome, and family history. Arch Gen Psychiatry. 1976; 33(10):11157-11160. https://doi.org/10.1007/978-1-59745-252-6_7 Seetharaman, A., Chauhan, V. S., Adhvaryu, A., & Prakash, J. Lorazepam challenge test: A unique clinical response in catatonia. Industrial Psychiatry Journal. 2021; 30(Suppl 1), S235. https://doi.org/10.4103/0972-6748.328871 Murray, MR., Egarton, A., Gao, Y., et al. Why Is Clozapine Uniquely Effective in Treatment-Resistant Schizophrenia? A Review and Proposal. Biological Psychiatry. 2025. https://doi.org/10.1016/j.biopsych.2025.06.011 Siskind, D., Northwood, K., McCutcheon, AR. Clozapine and treatment-resistant schizophrenia: efficacy versus effectiveness. The Lancet Psychiatry. 2025; 12(4): p240-241. Clozapine and treatment-resistant schizophrenia: efficacy versus effectiveness - The Lancet Psychiatry Saini, A., Begum, N., Matti, J., et al. (2024). Clozapine as a treatment for catatonia: A systematic review. ScienceDirect. 2024; 263: 275-281. https://doi.org/10.1016/j.schres.2022.09.021 Khandaker, MG., Cousins, L., Deakin, J., Lennox, RB., Yolken, R., Jones BP. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015; 2 (3): 258-270. https://doi.org/10.1016/S2215-0366(14)00122-9 Cruz Mosquera, F. E., Guevara-Montoya, M. C., Serna-Ramirez, V., Liscano, Y. Neuroinflammation and schizophrenia: new therapeutic strategies through psychobiotics, nanotechnology, and artificial Intelligence (AI). Journal of Personalized Medicine. 2024; 14(4): 391. https://doi.org/10.3390/jpm14040391